Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	hypotaurine monooxygenase activity	FMO2 FMO5	2.36e-04	5	98	2	GO:0047822
GeneOntologyMolecularFunction	ferroxidase activity	HEPH HEPHL1	3.53e-04	6	98	2	GO:0004322
GeneOntologyMolecularFunction	N,N-dimethylaniline monooxygenase activity	FMO2 FMO5	3.53e-04	6	98	2	GO:0004499
GeneOntologyMolecularFunction	oxidoreductase activity, acting on metal ions, oxygen as acceptor	HEPH HEPHL1	3.53e-04	6	98	2	GO:0016724
GeneOntologyMolecularFunction	disaccharide binding	LGALS9C LGALS9B	4.93e-04	7	98	2	GO:0048030
GeneOntologyMolecularFunction	protein serine/threonine kinase activator activity	LGALS9C LGALS9B CCNYL3 CCNYL2	5.89e-04	78	98	4	GO:0043539
GeneOntologyMolecularFunction	galactoside binding	LGALS9C LGALS9B	8.39e-04	9	98	2	GO:0016936
GeneOntologyMolecularFunction	calcium-dependent protein serine/threonine kinase activity	CAMK2A MAPKAPK3	1.05e-03	10	98	2	GO:0009931
GeneOntologyMolecularFunction	lipid kinase activity	PIKFYVE DGKK DGKI	1.07e-03	41	98	3	GO:0001727
GeneOntologyMolecularFunction	enzyme-substrate adaptor activity	APPBP2 DTX3L BTRC FBXW11	1.23e-03	95	98	4	GO:0140767
GeneOntologyMolecularFunction	ATP-dependent diacylglycerol kinase activity	DGKK DGKI	1.27e-03	11	98	2	GO:0004143
MousePheno	tracheoesophageal fistula	PCSK5 DYNC2H1 NKX2-1	4.80e-05	15	68	3	MP:0003321
MousePheno	abnormal dentate gyrus morphology	ZBTB20 CAMK2A UBE3B POU1F1 PAFAH1B1	6.02e-05	86	68	5	MP:0000812
MousePheno	enhanced humoral immune response	LGALS9C LGALS9B IGHG4	7.13e-05	17	68	3	MP:0020155
MousePheno	increased T-helper 1 cell number	LGALS9C LGALS9B TAP1	1.01e-04	19	68	3	MP:0008086
Domain	Cu-oxidase_2	F8 HEPH HEPHL1	5.08e-07	4	95	3	IPR011706
Domain	Cu-oxidase_2	F8 HEPH HEPHL1	5.08e-07	4	95	3	PF07731
Domain	Cu_oxidase_CS	F8 HEPH HEPHL1	1.27e-06	5	95	3	IPR033138
Domain	Cu-oxidase_3	F8 HEPH HEPHL1	1.27e-06	5	95	3	IPR011707
Domain	MULTICOPPER_OXIDASE1	F8 HEPH HEPHL1	1.27e-06	5	95	3	PS00079
Domain	Cu-oxidase_3	F8 HEPH HEPHL1	1.27e-06	5	95	3	PF07732
Domain	Cu_oxidase_Cu_BS	F8 HEPH HEPHL1	2.52e-06	6	95	3	IPR002355
Domain	ZINC_FINGER_C2H2_2	ZBTB20 ZNF234 ZNF366 ZNF423 ZNF322 MYNN ZFY RLF ZBTB45 ZBTB39 ZNF620 ZNF398 PRMT3 ZNF292 ZNF44	8.14e-06	775	95	15	PS50157
Domain	-	ZBTB20 ZNF234 ZNF366 ZNF423 ZNF322 MYNN ZFY RLF ZBTB45 ZBTB39 ZNF620 ZNF398 ZNF292 ZNF44	8.28e-06	679	95	14	3.30.160.60
Domain	ZINC_FINGER_C2H2_1	ZBTB20 ZNF234 ZNF366 ZNF423 ZNF322 MYNN ZFY RLF ZBTB45 ZBTB39 ZNF620 ZNF398 PRMT3 ZNF292 ZNF44	8.39e-06	777	95	15	PS00028
Domain	zf-C2H2	ZBTB20 ZNF234 ZNF366 ZNF423 ZNF322 MYNN ZFY RLF ZBTB45 ZBTB39 ZNF620 ZNF398 ZNF292 ZNF44	1.04e-05	693	95	14	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZBTB20 ZNF234 ZNF366 ZNF423 ZNF322 MYNN ZFY RLF ZBTB45 ZBTB39 ZNF620 ZNF398 ZNF292 ZNF44	1.06e-05	694	95	14	IPR013087
Domain	Znf_C2H2-like	ZBTB20 ZNF234 ZNF366 ZNF423 ZNF322 MYNN ZFY RLF ZBTB45 ZBTB39 ZNF620 ZNF398 PRMT3 ZNF292 ZNF44	1.12e-05	796	95	15	IPR015880
Domain	Znf_C2H2	ZBTB20 ZNF234 ZNF366 ZNF423 ZNF322 MYNN ZFY RLF ZBTB45 ZBTB39 ZNF620 ZNF398 PRMT3 ZNF292 ZNF44	1.28e-05	805	95	15	IPR007087
Domain	ZnF_C2H2	ZBTB20 ZNF234 ZNF366 ZNF423 ZNF322 MYNN ZFY RLF ZBTB45 ZBTB39 ZNF620 ZNF398 PRMT3 ZNF292 ZNF44	1.33e-05	808	95	15	SM00355
Domain	Beta-TrCP_D	BTRC FBXW11	2.56e-05	2	95	2	IPR021977
Domain	Beta-TrCP_D	BTRC FBXW11	2.56e-05	2	95	2	PF12125
Domain	Beta-TrCP_D	BTRC FBXW11	2.56e-05	2	95	2	SM01028
Domain	-	F8 HEPH HEPHL1	4.46e-05	14	95	3	2.60.40.420
Domain	MULTICOPPER_OXIDASE2	HEPH HEPHL1	7.65e-05	3	95	2	PS00080
Domain	Cu-oxidase	F8 HEPH	7.65e-05	3	95	2	PF00394
Domain	Cu-oxidase	F8 HEPH	7.65e-05	3	95	2	IPR001117
Domain	Cupredoxin	F8 HEPH HEPHL1	1.83e-04	22	95	3	IPR008972
Domain	FMO-like	FMO2 FMO5	2.53e-04	5	95	2	PF00743
Domain	Flavin_mOase	FMO2 FMO5	2.53e-04	5	95	2	IPR000960
Domain	Flavin_mOase-like	FMO2 FMO5	2.53e-04	5	95	2	IPR020946
Domain	DiMe-aniline_mOase	FMO2 FMO5	2.53e-04	5	95	2	IPR012143
Domain	IQ	RNF32 IQCF2 MYO10 UBE3B	4.70e-04	71	95	4	PF00612
Domain	IQ	RNF32 IQCF2 MYO10 UBE3B	7.75e-04	81	95	4	SM00015
Domain	WD40_repeat_dom	DMXL2 NWD1 SPAG9 WDR91 PAFAH1B1 BTRC FBXW11	8.02e-04	297	95	7	IPR017986
Domain	Peptidase_S8_subtilisin-rel	PCSK5 PCSK9	1.12e-03	10	95	2	IPR015500
Domain	DAGK_acc	DGKK DGKI	1.12e-03	10	95	2	PF00609
Domain	Diacylglycerol_kin_accessory	DGKK DGKI	1.12e-03	10	95	2	IPR000756
Domain	DAGKa	DGKK DGKI	1.12e-03	10	95	2	SM00045
Domain	SUBTILASE_ASP	PCSK5 PCSK9	1.12e-03	10	95	2	PS00136
Domain	SUBTILASE_HIS	PCSK5 PCSK9	1.12e-03	10	95	2	PS00137
Domain	SUBTILASE_SER	PCSK5 PCSK9	1.12e-03	10	95	2	PS00138
Domain	IQ_motif_EF-hand-BS	RNF32 IQCF2 MYO10 UBE3B	1.15e-03	90	95	4	IPR000048
Domain	IQ	RNF32 IQCF2 MYO10 UBE3B	1.30e-03	93	95	4	PS50096
Domain	-	PCSK5 PCSK9	1.37e-03	11	95	2	3.40.50.200
Domain	Peptidase_S8/S53_dom	PCSK5 PCSK9	1.37e-03	11	95	2	IPR000209
Domain	Peptidase_S8	PCSK5 PCSK9	1.37e-03	11	95	2	PF00082
Domain	-	DMXL2 NWD1 SPAG9 WDR91 PAFAH1B1 BTRC FBXW11	1.55e-03	333	95	7	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	DMXL2 NWD1 SPAG9 WDR91 PAFAH1B1 BTRC FBXW11	1.61e-03	335	95	7	IPR015943
Domain	WD40	DMXL2 NWD1 WDR91 PAFAH1B1 BTRC FBXW11	2.08e-03	259	95	6	PF00400
Domain	DAGKc	DGKK DGKI	2.24e-03	14	95	2	SM00046
Domain	WD40	DMXL2 NWD1 WDR91 PAFAH1B1 BTRC FBXW11	2.47e-03	268	95	6	SM00320
Domain	Diacylglycerol_kinase_cat_dom	DGKK DGKI	2.57e-03	15	95	2	IPR001206
Domain	Gal-bind_lectin	LGALS9C LGALS9B	2.57e-03	15	95	2	PF00337
Domain	DAGK_cat	DGKK DGKI	2.57e-03	15	95	2	PF00781
Domain	Gal-bind_lectin	LGALS9C LGALS9B	2.57e-03	15	95	2	SM00908
Domain	DAGK	DGKK DGKI	2.57e-03	15	95	2	PS50146
Domain	GALECTIN	LGALS9C LGALS9B	2.57e-03	15	95	2	PS51304
Domain	Galectin_CRD	LGALS9C LGALS9B	2.57e-03	15	95	2	IPR001079
Domain	GLECT	LGALS9C LGALS9B	2.57e-03	15	95	2	SM00276
Domain	WD40_repeat	DMXL2 NWD1 WDR91 PAFAH1B1 BTRC FBXW11	2.66e-03	272	95	6	IPR001680
Domain	WD_REPEATS_1	DMXL2 NWD1 WDR91 PAFAH1B1 BTRC FBXW11	2.96e-03	278	95	6	PS00678
Domain	WD_REPEATS_2	DMXL2 NWD1 WDR91 PAFAH1B1 BTRC FBXW11	3.02e-03	279	95	6	PS50082
Domain	WD_REPEATS_REGION	DMXL2 NWD1 WDR91 PAFAH1B1 BTRC FBXW11	3.02e-03	279	95	6	PS50294
Domain	Ig/MHC_CS	IGHG4 ULBP1 SIGLEC11	3.21e-03	58	95	3	IPR003006
Domain	Propept_inh	PCSK5 PCSK9	3.31e-03	17	95	2	IPR009020
Domain	NAD/diacylglycerol_kinase	DGKK DGKI	3.31e-03	17	95	2	IPR016064
Domain	IG_MHC	IGHG4 ULBP1 SIGLEC11	3.54e-03	60	95	3	PS00290
Domain	BTB	ZBTB20 MYNN ZBTB45 ZBTB39	4.50e-03	131	95	4	PF00651
Domain	Ank_2	ANK2 ANKRD30A DGKI ANKMY2 ANKS3	4.84e-03	215	95	5	PF12796
Pubmed	The C. elegans homolog of human panic-disorder risk gene TMEM132D orchestrates neuronal morphogenesis through the WAVE-regulatory complex.	SHLD2 TPST1 FMO2 ZBTB20 PRMT3	2.03e-06	72	99	5	33726789
Pubmed	β-TrCP-mediated IRAK1 degradation releases TAK1-TRAF6 from the membrane to the cytosol for TAK1-dependent NF-κB activation.	TRAF6 BTRC FBXW11	2.65e-06	10	99	3	22851693
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DMXL2 TRAF6 ZNF234 FN1 ANK2 CAMK2A ZNF423 MYNN LRRCC1 PLAUR SNRNP200 BTRC SEZ6L FBXW11 ZNF292	3.53e-06	1285	99	15	35914814
Pubmed	TRAF6 Suppresses the Development of Pulmonary Fibrosis by Attenuating the Activation of Fibroblasts.	TRAF6 TRIB3	8.02e-06	2	99	2	35668944
Pubmed	Constitutive and UV-induced fibronectin degradation is a ubiquitination-dependent process controlled by beta-TrCP.	FN1 BTRC	8.02e-06	2	99	2	16757476
Pubmed	The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts.	FN1 PLAUR	8.02e-06	2	99	2	14602715
Pubmed	In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.	FN1 NKX2-1	8.02e-06	2	99	2	18958156
Pubmed	Localization of human flavin-containing monooxygenase genes FMO2 and FMO5 to chromosome 1q.	FMO2 FMO5	8.02e-06	2	99	2	8786146
Pubmed	The characteristics and roles of β-TrCP1/2 in carcinogenesis.	BTRC FBXW11	8.02e-06	2	99	2	33021036
Pubmed	Specificity, location and function of βTrCP isoforms and their splice variants.	BTRC FBXW11	8.02e-06	2	99	2	21138764
Pubmed	Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells.	BTRC FBXW11	8.02e-06	2	99	2	37341489
Pubmed	Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain.	ZBTB20 CAMK2A	8.02e-06	2	99	2	29056297
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	APPBP2 MYO10 CAMK2A ZNF423 MROH1 XPO5 PLCL2 SEZ6L	2.22e-05	407	99	8	12693553
Pubmed	Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.	LGALS9C LGALS9B	2.40e-05	3	99	2	19776007
Pubmed	The cross talk of two family members of β-TrCP in the regulation of cell autophagy and growth.	BTRC FBXW11	2.40e-05	3	99	2	31406304
Pubmed	Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis.	LGALS9C LGALS9B	2.40e-05	3	99	2	33316546
Pubmed	A dual role for caveolin-1 in the regulation of fibronectin matrix assembly by uPAR.	FN1 PLAUR	2.40e-05	3	99	2	18957516
Pubmed	Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin.	LGALS9C LGALS9B	2.40e-05	3	99	2	9038233
Pubmed	The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: functional consequences of natural mutations and post-translational modifications.	PCSK5 PCSK9	2.40e-05	3	99	2	16912035
Pubmed	Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.	LGALS9C LGALS9B	2.40e-05	3	99	2	28704475
Pubmed	Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.	LGALS9C LGALS9B	2.40e-05	3	99	2	23836896
Pubmed	Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes.	LGALS9C LGALS9B	2.40e-05	3	99	2	7890611
Pubmed	Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.	LGALS9C LGALS9B	2.40e-05	3	99	2	22341088
Pubmed	Galectin-9 Is a Novel Regulator of Epithelial Restitution.	LGALS9C LGALS9B	2.40e-05	3	99	2	32380082
Pubmed	Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.	LGALS9C LGALS9B	2.40e-05	3	99	2	23667648
Pubmed	Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.	LGALS9C LGALS9B	2.40e-05	3	99	2	28877989
Pubmed	Stability of Wake-Sleep Cycles Requires Robust Degradation of the PERIOD Protein.	BTRC FBXW11	2.40e-05	3	99	2	29103939
Pubmed	Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.	LGALS9C LGALS9B	2.40e-05	3	99	2	19800850
Pubmed	The effect of Toxoplasma gondii infection on galectin-9 expression in decidual macrophages contributing to dysfunction of decidual NK cells during pregnancy.	LGALS9C LGALS9B	2.40e-05	3	99	2	38987795
Pubmed	SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation.	BTRC FBXW11	2.40e-05	3	99	2	18354483
Pubmed	Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.	LGALS9C LGALS9B	2.40e-05	3	99	2	37105392
Pubmed	Proteasomal degradation of eukaryotic elongation factor-2 kinase (EF2K) is regulated by cAMP-PKA signaling and the SCFβTRCP ubiquitin E3 ligase.	BTRC FBXW11	2.40e-05	3	99	2	23640883
Pubmed	Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson's disease.	LGALS9C LGALS9B	2.40e-05	3	99	2	36479526
Pubmed	Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.	LGALS9C LGALS9B	2.40e-05	3	99	2	23242525
Pubmed	Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.	LGALS9C LGALS9B	2.40e-05	3	99	2	19851072
Pubmed	The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.	LGALS9C LGALS9B	2.40e-05	3	99	2	33923930
Pubmed	Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases.	LGALS9C LGALS9B	2.40e-05	3	99	2	31969388
Pubmed	The role of {beta}-TrCP1 and {beta}-TrCP2 in circadian rhythm generation by mediating degradation of clock protein PER2.	BTRC FBXW11	2.40e-05	3	99	2	18782782
Pubmed	[Ceruloplasmin, hephaestin and zyklopen: the three multicopper oxidases important for human iron metabolism].	HEPH HEPHL1	2.40e-05	3	99	2	24988611
Pubmed	Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.	LGALS9C LGALS9B	2.40e-05	3	99	2	35241678
Pubmed	Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.	LGALS9C LGALS9B	2.40e-05	3	99	2	22627368
Pubmed	Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in mice.	LGALS9C LGALS9B	2.40e-05	3	99	2	33153471
Pubmed	T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.	LGALS9C LGALS9B	2.40e-05	3	99	2	22052881
Pubmed	Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner.	LGALS9C LGALS9B	2.40e-05	3	99	2	35643073
Pubmed	Galectin-9 functionally impairs natural killer cells in humans and mice.	LGALS9C LGALS9B	2.40e-05	3	99	2	23408620
Pubmed	Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis.	LGALS9C LGALS9B	2.40e-05	3	99	2	29458010
Pubmed	Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9.	LGALS9C LGALS9B	2.40e-05	3	99	2	26582205
Pubmed	In vivo evidence that furin from hepatocytes inactivates PCSK9.	PCSK5 PCSK9	2.40e-05	3	99	2	21147780
Pubmed	Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.	LGALS9C LGALS9B	2.40e-05	3	99	2	9153289
Pubmed	Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice.	LGALS9C LGALS9B	2.40e-05	3	99	2	18974023
Pubmed	Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation.	BTRC FBXW11	2.40e-05	3	99	2	17121803
Pubmed	Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion.	LGALS9C LGALS9B	2.40e-05	3	99	2	23144904
Pubmed	Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings.	LGALS9C LGALS9B	2.40e-05	3	99	2	29651447
Pubmed	The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity.	LGALS9C LGALS9B	2.40e-05	3	99	2	21146220
Pubmed	Degradation of human Lipin-1 by BTRC E3 ubiquitin ligase.	BTRC FBXW11	2.40e-05	3	99	2	28483528
Pubmed	Critical role for IL-1β in DNA damage-induced mucositis.	BTRC FBXW11	2.40e-05	3	99	2	24469832
Pubmed	Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9.	LGALS9C LGALS9B	2.40e-05	3	99	2	28990062
Pubmed	Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.	LGALS9C LGALS9B	2.40e-05	3	99	2	18579572
Pubmed	The ubiquitin ligase subunit β-TrCP in Sertoli cells is essential for spermatogenesis in mice.	BTRC FBXW11	2.40e-05	3	99	2	30391586
Pubmed	Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.	LGALS9C LGALS9B	2.40e-05	3	99	2	16990264
Pubmed	Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.	LGALS9C LGALS9B	2.40e-05	3	99	2	18005988
Pubmed	Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.	LGALS9C LGALS9B	2.40e-05	3	99	2	23585851
Pubmed	Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.	LGALS9C LGALS9B	2.40e-05	3	99	2	24477688
Pubmed	A unique role for galectin-9 in angiogenesis and inflammatory arthritis.	LGALS9C LGALS9B	2.40e-05	3	99	2	29433546
Pubmed	Alarmin function of galectin-9 in murine respiratory tularemia.	LGALS9C LGALS9B	2.40e-05	3	99	2	25898318
Pubmed	Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells.	LGALS9C LGALS9B	2.40e-05	3	99	2	31937306
Pubmed	Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine.	LGALS9C LGALS9B	2.40e-05	3	99	2	21426359
Pubmed	Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis.	LGALS9C LGALS9B	2.40e-05	3	99	2	18282810
Pubmed	Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations.	LGALS9C LGALS9B	2.40e-05	3	99	2	24083426
Pubmed	Kinesin adapter JLP links PIKfyve to microtubule-based endosome-to-trans-Golgi network traffic of furin.	SPAG9 PIKFYVE	2.40e-05	3	99	2	19056739
Pubmed	Galectin-9 in synergy with NF-κB inhibition restores immune regulatory capability in dendritic cells of subjects with food allergy.	LGALS9C LGALS9B	2.40e-05	3	99	2	37279535
Pubmed	The protective function of galectin-9 in liver ischemia and reperfusion injury in mice.	LGALS9C LGALS9B	2.40e-05	3	99	2	25931247
Pubmed	Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.	BTRC FBXW11	2.40e-05	3	99	2	22045853
Pubmed	Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes.	LGALS9C LGALS9B	2.40e-05	3	99	2	17560833
Pubmed	Localization of ubiquitin gene family members to mouse chromosomes 5, 11, and 18.	LGALS9C CDO1 LGALS9B	2.46e-05	20	99	3	9321482
Pubmed	ZBTB20 is crucial for the specification of a subset of callosal projection neurons and astrocytes in the mammalian neocortex.	ZBTB20 MYNN ZBTB45 ZBTB39	3.23e-05	63	99	4	34351428
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DMXL2 SPAG9 HEPH NLN XPO5 SNRNP200	4.65e-05	225	99	6	12168954
Pubmed	β-TrCP-dependent degradation of ASK1 suppresses the induction of the apoptotic response by oxidative stress.	BTRC FBXW11	4.79e-05	4	99	2	30031111
Pubmed	SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9.	LGALS9C LGALS9B	4.79e-05	4	99	2	38686388
Pubmed	Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.	LGALS9C LGALS9B	4.79e-05	4	99	2	22677125
Pubmed	Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.	LGALS9C LGALS9B	4.79e-05	4	99	2	19234217
Pubmed	S6 Kinase- and β-TrCP2-Dependent Degradation of p19Arf Is Required for Cell Proliferation.	BTRC FBXW11	4.79e-05	4	99	2	26240281
Pubmed	Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis.	LGALS9C LGALS9B	4.79e-05	4	99	2	35715604
Pubmed	Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.	LGALS9C LGALS9B	4.79e-05	4	99	2	19017954
Pubmed	Galectin-9: A novel promoter of atherosclerosis progression.	LGALS9C LGALS9B	4.79e-05	4	99	2	36459823
Pubmed	Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models.	LGALS9C LGALS9B	4.79e-05	4	99	2	29611821
Pubmed	Identification of seven loci affecting mean telomere length and their association with disease.	MYNN STN1	4.79e-05	4	99	2	23535734
Pubmed	Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis.	BTRC FBXW11	4.79e-05	4	99	2	19270156
Pubmed	Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2.	LGALS9C LGALS9B	4.79e-05	4	99	2	33727589
Pubmed	The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy.	LGALS9C LGALS9B	4.79e-05	4	99	2	25578313
Pubmed	The Tumor Suppressor MIG6 Controls Mitotic Progression and the G2/M DNA Damage Checkpoint by Stabilizing the WEE1 Kinase.	BTRC FBXW11	4.79e-05	4	99	2	30067982
Pubmed	Oxidative stress-induced ubiquitination of RCAN1 mediated by SCFbeta-TrCP ubiquitin ligase.	BTRC FBXW11	4.79e-05	4	99	2	18575781
Pubmed	[Expression and significance of galectin-3 and galectin-9 in mice nasal mucosa with allergic rhinitis].	LGALS9C LGALS9B	4.79e-05	4	99	2	18826117
Pubmed	SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response.	BTRC FBXW11	4.79e-05	4	99	2	16885022
Pubmed	The expression of Galectin-9 correlates with mTOR and AMPK in murine colony-forming erythroid progenitors.	LGALS9C LGALS9B	4.79e-05	4	99	2	38853593
Pubmed	PLK1 and β-TrCP-dependent ubiquitination and degradation of Rap1GAP controls cell proliferation.	BTRC FBXW11	4.79e-05	4	99	2	25329897
Pubmed	[Expression of Galectin-9 and Tim-3 in lungs of mice with asthma].	LGALS9C LGALS9B	4.79e-05	4	99	2	21575348
Pubmed	Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.	LGALS9C LGALS9B	4.79e-05	4	99	2	18346632
Pubmed	Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice.	LGALS9C LGALS9B	4.79e-05	4	99	2	19670381
Pubmed	Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.	LGALS9C LGALS9B	4.79e-05	4	99	2	25450716
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZBTB20 ZNF234 ZNF366 ZNF423 ZNF322 MYNN ZFY RLF ZBTB45 ZBTB39 ZNF620 ZNF398 ZNF292 ZNF44	2.97e-07	718	67	14	28
GeneFamily	WD repeat domain containing	DMXL2 NWD1 WDR91 PAFAH1B1 BTRC FBXW11	4.16e-04	262	67	6	362
GeneFamily	Proprotein convertase subtilisin/kexin family	PCSK5 PCSK9	4.79e-04	9	67	2	973
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKK DGKI	5.97e-04	10	67	2	1178
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	BTRC FBXW11	7.28e-04	11	67	2	559
GeneFamily	Galectins	LGALS9C LGALS9B	1.38e-03	15	67	2	629
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	ZBTB20 MYNN ZBTB45 ZBTB39	1.54e-03	134	67	4	861
GeneFamily	Ankyrin repeat domain containing	ANK2 ANKRD30A DGKI ANKMY2 ANKS3	2.03e-03	242	67	5	403
GeneFamily	Olfactory receptors, family 1	OR1F12P OR1L8	9.64e-03	40	67	2	147
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TPST1 DMXL2 APPBP2 ZBTB20 MYO10 SPG11 SPAG9 RLF PIKFYVE PAFAH1B1 TUBGCP3 ANKMY2 PLAUR PRMT3 BTRC FBXW11 ZNF292	1.79e-08	856	98	17	M4500
Coexpression	KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN	PCSK5 TPST1 ZBTB20 MROH1 ZNF398 PRMT3 ADGRD1	1.04e-05	200	98	7	M3025
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	CDO1 FMO2 FN1 SGCA MYO10 WDR91	5.06e-06	198	98	6	e0e47cf65774191981840b22905b2094b95abe0f
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PCSK5 TPST1 CDO1 FN1 ANK2 ADGRD1	5.36e-06	200	98	6	74ad0ae592252060ee294d7483327d765a6ba1dd
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-\|Thalamus / BrainAtlas - Mouse McCarroll V32	AMPD1 FMO2 ZNF366 ULBP1	3.10e-05	81	98	4	f7f2adf1fecd34b444de92d4c1bf45eb0281f4ad
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)\|Thalamus / BrainAtlas - Mouse McCarroll V32	AMPD1 FMO2 ZNF366 ULBP1	3.10e-05	81	98	4	8d323402ee5fb450947b00b0d75ca8f07aa4769e
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--\|Thalamus / BrainAtlas - Mouse McCarroll V32	AMPD1 FMO2 ZNF366 ULBP1	3.10e-05	81	98	4	55cbf579d93e14bc4aebbed0fd11076c9313cdac
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C9orf85 SHLD2 TRIB3 PLAUR ZNF292	3.71e-05	170	98	5	6210ee3bf29059e6149c047bb7e02c5f59441519
ToppCell	metastatic_Brain-Endothelial_cells-Lymphatic_ECs\|Endothelial_cells / Location, Cell class and cell subclass	FMO2 SGCA F8 LRRCC1 ADGRD1	4.38e-05	176	98	5	42541dfe20eb29625d47c0bb79bf3c21a2460340
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|390C / Donor, Lineage, Cell class and subclass (all cells)	DMXL2 ZBTB45 MROH1 LRRCC1 PDP2	5.27e-05	183	98	5	228092290dbb08785c4eda224e3ad03e99e10fab
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	FMO2 FN1 SGCA MYO10 HEPH	6.30e-05	190	98	5	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TPST1 AMPD1 FN1 DYNC2H1 SGCA	6.45e-05	191	98	5	cc9a6a8fad17d6e1a08a68ab7512ae06b1249051
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TPST1 AMPD1 FN1 DYNC2H1 SGCA	6.45e-05	191	98	5	c16b920ee69ea8536e020ac3475abf1ce972c1e6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FMO2 FN1 ZNF366 ZNF423 F8	6.61e-05	192	98	5	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FMO2 FN1 ZNF366 ZNF423 F8	6.78e-05	193	98	5	52e918884877b6659cdca0496390e440f73694a9
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCSK5 F8 ZFY PDP2 S100PBP	6.95e-05	194	98	5	6be74e4ba631b0c46cef2c580553f4c1ed29579e
ToppCell	343B-Endothelial_cells-Endothelial-B_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PCSK5 CDO1 FMO2 FN1 F8	6.95e-05	194	98	5	582db7f7fa9aa08027ae18ed607945b5d1dc908a
ToppCell	368C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CDO1 FMO2 FN1 SGCA MYO10	6.95e-05	194	98	5	d9eec28fa7b255c0ec023276dd955f1e276e7159
ToppCell	(5)_Fibroblast-C_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CDO1 FMO2 FN1 SGCA HEPH	6.95e-05	194	98	5	29a72e565c19407bbd198cfbc2a78106fe830d05
ToppCell	368C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CDO1 FMO2 FN1 SGCA MYO10	6.95e-05	194	98	5	e4d7e9709ce42d4610e44d3445927eefbcbb9eff
ToppCell	343B-Endothelial_cells-Endothelial-B_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PCSK5 CDO1 FMO2 FN1 F8	6.95e-05	194	98	5	bda89111386398a072b70e8153b2a762298a047a
ToppCell	Tracheal-10x3prime_v2-Stromal-Mesofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 FN1 ANK2 EARS2 SGCA	7.47e-05	197	98	5	d7cef7881abd807a679432766ced609a6efd1067
ToppCell	Fibroblast\|World / shred by cell class for bronchial biopsy	CDO1 FN1 SGCA HEPH ADGRD1	7.47e-05	197	98	5	8bf9846228b6b6721b10375fe54a2fb389ff64a6
ToppCell	Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 FN1 ANK2 EARS2 SGCA	7.47e-05	197	98	5	20a5958512bdb99daeb8f4d244df53e4f048f879
ToppCell	Control-Stromal-Fibroblast\|Stromal / Disease state, Lineage and Cell class	PCSK5 TPST1 ANK2 SPAG9 ADGRD1	7.47e-05	197	98	5	64cc5f61c88e9560b0f8f6f3151255dffb5c3d66
ToppCell	AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	FMO5 MS4A15 NKX2-1 PDP2 ADGRD1	7.65e-05	198	98	5	893036558a9ad86b57f9e735df35812e9d18739e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDO1 FMO2 FN1 ANK2 SGCA	7.83e-05	199	98	5	0019cfaa586a450c2e4952d1184a540561c8d0ba
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMO5 SPAG9 NKX2-1 ADGRD1 PCSK9	7.83e-05	199	98	5	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	CDO1 FMO2 FN1 SGCA HEPH	7.83e-05	199	98	5	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	CDO1 FMO2 FN1 SGCA HEPH	7.83e-05	199	98	5	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CDO1 FN1 ANK2 ZNF423 ADGRD1	8.02e-05	200	98	5	2022df85df94ab8cbb4e80e3fe9894c01051c5e0
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial\|10w / Sample Type, Dataset, Time_group, and Cell type.	SLC36A1 FMO2 FN1 SGCA PCSK9	8.02e-05	200	98	5	ff0b2675c68e9fc1fa16b3276431f199f3642eac
ToppCell	Bronchus_Control_(B.)-Stromal-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CDO1 FN1 ANK2 ZNF423 ADGRD1	8.02e-05	200	98	5	69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell\|10w / Sample Type, Dataset, Time_group, and Cell type.	SLC36A1 FMO2 FN1 SGCA PCSK9	8.02e-05	200	98	5	07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PCSK5 CDO1 FN1 ANK2 ADGRD1	8.02e-05	200	98	5	7ba292c30d915e66ebc8026fa76492cedf64700e
ToppCell	Tracheal-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PCSK5 CDO1 FN1 ANK2 ADGRD1	8.02e-05	200	98	5	920e6036c0a9c0089d0d898673daf9dd9d7279fc
ToppCell	Biopsy_IPF-Mesenchymal-Myofibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	CDO1 FN1 SGCA HEPH CORIN	8.02e-05	200	98	5	c2c6f687c49ba790174b27c7b8b084af30b34c86
Computational	Neighborhood of MAP1B	RALGAPA1 APPBP2 SPAG9 BTRC FBXW11	2.08e-05	65	56	5	GCM_MAP1B
Computational	Neighborhood of RAP2A	RALGAPA1 SPAG9 TUBGCP3 FBXW11	2.73e-05	34	56	4	GCM_RAP2A
Computational	Neighborhood of MAP4K4	RALGAPA1 APPBP2 MYO10 SPAG9 BTRC FBXW11	2.57e-04	172	56	6	GCM_MAP4K4
Computational	Neighborhood of RAN	RALGAPA1 APPBP2 SPAG9 TUBGCP3 BTRC FBXW11	5.18e-04	196	56	6	GCM_RAN
Disease	Menkes disease (implicated_via_orthology)	BTRC FBXW11	9.77e-05	5	93	2	DOID:1838 (implicated_via_orthology)
Disease	VACTERL association (implicated_via_orthology)	PCSK5 DYNC2H1	1.46e-04	6	93	2	DOID:14679 (implicated_via_orthology)
Disease	glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement	CORIN PCSK9	2.04e-04	7	93	2	EFO_0800551
Disease	glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement	CORIN PCSK9	3.49e-04	9	93	2	EFO_0800476
Disease	Epithelioid Cell Uveal Melanoma	OR1L8 DGKI	5.31e-04	11	93	2	EFO_1000244
Disease	Situs Inversus	PKD1L1 ANKS3	5.31e-04	11	93	2	C0037221
Disease	mitochondrial DNA measurement	ZBTB20 FMO5 ZNF366 PLAUR CAPZA3 PCSK9	6.10e-04	328	93	6	EFO_0006312
Disease	vascular brain injury measurement, vascular brain injury	PCSK5 SEZ6L	7.49e-04	13	93	2	EFO_0006791, EFO_0006800
Disease	Congenital Hypothyroidism	POU1F1 NKX2-1	7.49e-04	13	93	2	C0010308
Disease	myocardial infarction	FN1 DYNC2H1 DCLRE1B STN1 PLCL2 PCSK9	8.55e-04	350	93	6	EFO_0000612
Disease	stem Cell Growth Factor beta measurement	PCSK5 TTC41P ZNF44	1.74e-03	75	93	3	EFO_0008292

Protein segments in the cluster

Peptide	Gene	Start	Entry
VFYLGQHAMECHHRI	TPST1	21	O60507
EKLMHHQGECAGHQH	CAPZA3	41	Q96KX2
SHEVFAMHLCRHLQL	ACY3	131	Q96HD9
AHTKIAEAMHHQDCL	ADGRD1	441	Q6QNK2
HHCEAVLHLRFNNGM	BTRC	381	Q9Y297
VTCGFHHIHEQIMEY	ANKRD30A	246	Q9BXX3
RHLLHHCFQALMDHG	APPBP2	76	Q92624
ICPISHHEMQAHIFH	AMPD1	46	P23109
DTHIHAAACMNQKHL	AMPD1	301	P23109
HHNGFVSKEFSMHVC	DMXL2	1091	Q8TDJ6
AGRIHAVDHMEICHS	DCLRE1B	226	Q9H816
HFDEHCLPSTIHGDM	EFCAB12	366	Q6NXP0
HVIHMLTGHTGEVRC	NWD1	901	Q149M9
AAMQQHAVGHHGAVT	NKX2-1	51	P43699
GFECIRTMHGHDHNV	PAFAH1B1	181	P43034
SMAHAQLCFHGHRDA	SPAG9	1211	O60271
LHMAAQGDHVECVKH	ANK2	336	Q01484
HHHRIAQCHEVMITI	DGKK	986	Q5KSL6
LMMAHLHFCSDNVIH	OR1F12P	161	Q8NHA8
HIVCILDVYENMHHG	MAPKAPK3	96	Q16644
HINLCSGSHIAFHMN	LGALS9C	256	Q6DKI2
HINLCSGSHIAFHMN	LGALS9B	256	Q3B8N2
FVAGEGLHMHHICER	CCNYL2	56	Q5T2Q4
ANLVLHMDDSHCLHC	PCSK5	1691	Q92824
MGTRVHCHQQGHVLT	PCSK9	546	Q8NBP7
NIIAHTFCEHMGIAH	OR52B6	191	Q8NGF0
FVEHLISRMCHYQHG	FBXW11	91	Q9UKB1
CQLVFHSRMHHGEEK	MYNN	371	Q9NPC7
FMFEQAHEAVIHGHH	MYO10	1806	Q9HD67
LHQCHILASEMVHFI	TUBGCP3	701	Q96CW5
LLFCHISSHQHDGME	F8	326	P00451
FGEFLNTTCKHLMHH	MROH1	1546	Q8NDA8
GATACMAHVDGIHLH	PDP2	266	Q9P2J9
EIHQVLMDHGVPCHY	CCNYL3	256	P0C7X3
KICHHSSGMEFQDHR	PIKFYVE	361	Q9Y2I7
TVMNGLSHLHGCRDH	DYNC2H1	2171	Q8NCM8
MHQHEGHIPNAVDSC	DTX3L	116	Q8TDB6
HCKSEHQFNIDSMVH	PRMT3	66	O60678
QAFHNKVTCFMLHHI	DGKI	291	O75912
FHKRHEEGHMLNCTC	FN1	531	P02751
HDHTNSHCFLKMLQG	CDO1	86	Q16878
FDGVMVCTGHHTNAH	FMO5	141	P49326
LEVDHFMHCNISSHS	GRPR	11	P30550
DVNCHQHEHGYTALM	ANKMY2	71	Q8IV38
FLMVHRAATEHHVCA	CORIN	701	Q9Y5Q5
TAVIAMHFGCQAIHA	MS4A15	186	Q8N5U1
LLHCHVSDHIHAGME	HEPHL1	1046	Q6MZM0
HCTSAGHQHMVRFLL	ANKS3	141	Q6ZW76
GHCVVTATHLQFHIE	IQCF2	146	Q8IXL9
DAVMVCSGHHILPHI	FMO2	141	Q99518
CELHEGRNHMAVHSC	LINC02913	91	Q8NAJ2
NVFSCSVMHEALHNH	IGHG4	301	P01861
HCVHMSEPQHVASII	SERHL2	286	Q9H4I8
ELCALMDQVHHMQHS	S100PBP	346	Q96BU1
HHHAQLIFVFLVEMG	C9orf85	151	Q96MD7
MACQVQPHHGLEAHT	PKD1L1	1196	Q8TDX9
HHLVFHVANICFAVG	BVES	41	Q8NE79
TMSHHHCVLLVAFSC	OR1L8	136	Q8NGR8
NHMEKGCHFLHILAC	STN1	316	Q9H668
VMDLHSGGVAHFHCH	SEZ6L	406	Q9BYH1
EETAIEMPCHHLFHS	RNF181	86	Q9P0P0
IMHHSAAECLPVSNH	POU1F1	26	P28069
CHVTDHVHAGMETLF	HEPH	1046	Q9BQS7
VHCQKAAMEFHEHLH	PLCL2	1026	Q9UPR0
EMALLSCSHVFHHAC	RNF32	316	Q9H0A6
HFLANCMNRHVHVKD	SHLD2	76	Q86V20
NTMGHVHSHLQGEVF	TAP1	251	Q03518
EAVLHCHQMGVVHRD	CAMK2A	121	Q9UQM7
EHGHVHITDFNIAAM	STK32A	156	Q8WU08
TSDIQMVHHCTIHGN	SGCA	326	Q16586
PTYHLACVVDDHHMG	EARS2	226	Q5JPH6
ACVVDDHHMGISHVL	EARS2	231	Q5JPH6
FHEFGHVMHQICAQT	NLN	496	Q9BYT8
LAHHCFTLTCHMEGI	SPG11	2121	Q96JI7
CFQSQEHKHHMVCGI	TRIML2	41	Q8N7C3
EHKHHMVCGIQEAAE	TRIML2	46	Q8N7C3
HAHLGDAFSMNHIDV	PLAUR	271	Q03405
HMFIHSGEKPHQCAV	ZBTB45	421	Q96K62
TVAHVACNMLHMLVH	RALGAPA1	1331	Q6GYQ0
CNRVLGIHHISVMHS	RHCE	316	P18577
ALHMCVEHSEHTQYP	RLF	1536	Q13129
AVHCMGILVKCAHHF	SLC36A1	91	Q7Z2H8
MATALAHCHQHGLVL	TRIB3	166	Q96RU7
RHLEDHQAHCEFALM	TRAF6	146	Q9Y4K3
HHCGKNLSQDMLLTH	ZNF398	346	Q8TD17
IQMADFHRHEKCHTG	ZNF620	206	Q6ZNG0
AHCQLVHHFTTEEMV	ZNF292	1966	O60281
HMHEIIQIDGHIYQC	ZNF322	31	Q6U7Q0
LAGHLLASDSCHHVM	TTC41P	1051	Q6P2S7
QMHGQHDGCMASLVH	XPO5	1081	Q9HAV4
CYISALHIHQRVHMG	ZNF234	186	Q14588
HMFVHTGEKPHQCSI	ZBTB20	596	Q9HC78
HMAVHQSLEDALFHC	ZBTB39	526	O15060
SHLDHCMHDHFNAEI	SNRNP200	1726	O75643
HICANIMGHLNQHGF	UBE3B	191	Q7Z3V4
CGMEFVQPHHLKQHS	ZNF366	426	Q8N895
LQARMSCEHEAHGHG	ULBP1	121	Q9BZM6
HVANHMIEEGINHEC	ZNF423	1186	Q2M1K9
QEEYGEHHSSIMHCR	WDR91	401	A4D1P6
LHMLFLHHAFQMDSC	UHRF1BP1	661	Q6BDS2
FCHLGSFQRHMIMHS	ZNF44	366	P15621
IQMEHEGEFTCHAQH	SIGLEC11	426	Q96RL6
MHVCDIGHVEHMVHD	ZFY	141	P08048
HHLLQCMVGLHFLTN	LRRCC1	151	Q9C099